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TRPA1 is an excitatory ion channel targeted
by pungent irritants from mustard and garlic.
TRPA1 has been proposed to function in di-
verse sensory processes, including thermal
(cold) nociception, hearing, and inflammatory
pain. Using TRPA1-deficient mice, we now
show that this channel is the sole target through
whichmustard oil and garlic activate primary af-
ferent nociceptors to produce inflammatory
pain. TRPA1 is also targeted by environmental
irritants, such as acrolein, that account for toxic
and inflammatory actions of tear gas, vehicle
exhaust, and metabolic byproducts of chemo-
therapeutic agents. TRPA1-deficient mice dis-
play normal cold sensitivity and unimpaired au-
ditory function, suggesting that this channel is
not required for the initial detection of noxious
cold or sound. However, TRPA1-deficient mice
exhibit pronounced deficits in bradykinin-
evoked nociceptor excitation and pain hyper-
sensitivity. Thus, TRPA1 is an important com-
ponent of the transduction machinery through
which environmental irritants and endogenous
proalgesic agents depolarize nociceptors to
elicit inflammatory pain.
INTRODUCTION
Somatosensory neurons enable us to detect a wide range
of endogenous and environmental stimuli, including pres-
sure, temperature, irritants, and products of inflammation.
A subset of these neurons, collectively referred to as noci-
ceptors, can be activated by stimuli capable of eliciting tis-Csue damage or pain (Julius and Basbaum, 2001). A funda-
mental goal toward understanding the mechanisms of
somatosensation, nociception, and pain is to identify mol-
ecules that contribute to stimulus detection and promote
sensitization or excitation of primary sensory nerve fibers.
In this regard, significant attention has focused on mem-
bers of the TRP family of cation channels that serve as re-
ceptors for a variety of natural plant products that robustly
excite nociceptors to elicit pain and inflammation (Clap-
ham, 2003; Wang and Woolf, 2005). These include
TRPV1, a heat-activated channel that also functions as
the receptor for capsaicin (the pungent ingredient in chili
peppers) and TRPM8, a cold-activated channel that is tar-
geted by menthol and other cooling agents (Jordt et al.,
2003).
TRPA1 (formerly ANKTM1) is yet another member of the
TRP channel family that has attracted attention for its po-
tential role in nociception. Heterologously expressed
TRPA1 channels can be activated by isothiocyanate or
thiosulfinate compounds, which constitute the pungent in-
gredients of mustard oil and garlic, respectively (Bandell
et al., 2004; Bautista et al., 2005; Jordt et al., 2004; Mac-
pherson et al., 2005). Topical application of these agents
has long been known to excite sensory nerve fibers,
thereby producing acute pain and neurogenic inflamma-
tion through peripheral release of neuropeptides (sub-
stance P and CGRP), purines, and other transmitters
from activated nerve endings. This, in turn, produces ro-
bust hypersensitivity to thermal and mechanical stimuli.
TRPA1 is selectively expressed by a subset of unmyelin-
ated, peptidergic nociceptors that also express TRPV1,
consistent with its involvement in this signaling pathway
(Bautista et al., 2005; Story et al., 2003). Indeed, neuronal
sensitivity to mustard oil correlates with TRPA1 expres-
sion in vivo (Jordt et al., 2004; Nagata et al., 2005), but
whether this channel represents the exclusive target of
mustard-oil action has not been directly determined. A re-
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which TRPA1 serves as a receptor for other environmental
or metabolic irritants that act on sensory nerve endings
within the lung, bladder, or other visceral and vascular or-
gans to produce inflammation, vasodilation, and edema.
A topic of particularly vigorous debate concerns endog-
enous physiological roles for TRPA1 in sensory transduc-
tion. Story et al. have reported that heterologously ex-
pressed TRPA1 channels are activated when ambient
temperatures drop below 17ºC, leading them to propose
that TRPA1 functions as a detector of noxious cold
in vivo (Story et al., 2003). However, cold sensitivity of re-
combinant TRPA1 channels has not been universally
observed. Moreover, the percentage of neurons in rat tri-
geminal ganglia that express TRPA1 or respond to mus-
tard oil is significantly greater than that exhibiting cold
sensitivity, and thus, a role for TRPA1 in cold transduction
remains controversial (Jordt et al., 2004; Nagata et al.,
2005; Reid, 2005). In addition to its proposed role as
a cold sensor, histological and RNAi studies have led to
the suggestion that TRPA1 constitutes a component of
mechanically gated transduction channels in auditory
hair cells (Corey et al., 2004). However, heterologously ex-
pressed TRPA1 channels have not been shown to be me-
chanosensitive, nor have hair cells been shown to respond
to mustard oil or other TRPA1 agonists. Thus, direct phys-
iological, pharmacological, or genetic evidence to support
a role for TRPA1 in mechanosensation is still lacking.
In addition to being directly gated by physical or chem-
ical stimuli, many TRP channels are activated or modu-
lated downstream of neurotransmitter or growth-factor re-
ceptors that stimulate phospholipase C (PLC) (Montell
et al., 2002). In fact, in vitro studies have shown that
TRPA1 can be activated in this manner, raising the possi-
bility that it functions as a ‘‘receptor-operated’’ channel
that depolarizes nociceptors in response to proalgesic
or proinflammatory agents that activate PLC (Bandell
et al., 2004; Jordt et al., 2004). One such agent is bradyki-
nin, a nonapeptide that is produced in response to tissue
injury, inflammation, or ischemia and which binds to PLC-
coupled (BK2) receptors on sensory neurons (McMahon
et al., 2006). Bradykinin elicits acute pain through immedi-
ate excitation of nociceptors, followed by a longer lasting
sensitization to thermal and mechanical stimuli (Dray and
Perkins, 1993). Genetic and electrophysiological studies
suggest that bradykinin-evoked thermal hypersensitivity
is produced through PLC-mediated potentiation of TRPV1
(Cesare et al., 1999; Chuang et al., 2001; Premkumar
and Ahern, 2000). In contrast, the molecular mechanism
(or mechanisms) underlying acute depolarization are less
clear but likely involve activation of other cationic channels
in addition to TRPV1 (Dunn and Rang, 1990; Kollarik and
Undem, 2004). Whether TRPA1 contributes to acute exci-
tation or sensitization of nociceptors by bradykinin, or
other proalgesic agents, has yet to be determined.
Here we address a number of these questions by char-
acterizing cellular and behavioral deficits in mice lacking
functional TRPA1 channels. First, we prove that TRPA1
constitutes the obligate site of mustard oil or garlic action1270 Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc.on nociceptors since mice lacking this channel are com-
pletely unresponsive to isothiocyanate or thiosulfinate
compounds. We also show that TRPA1 is targeted by
other environmental irritants, such as unsaturated alde-
hydes present in smoke or produced by drug metabolism,
which elicit pain syndromes associated with inflammation
and edema. With regard to thermal sensitivity, we found
that lack of TRPA1 has no effect on the prevalence of
cold-sensitive primary afferent neurons or the magnitude
of their responses, suggesting that TRPA1 plays no signif-
icant role in acute cold detection. Similarly, TRPA1-
deficient mice exhibit no overt vestibular defects and dis-
play normal auditory responses, suggesting that TRPA1 is
not required for hearing. In contrast, TRPA1-deficient
mice showed substantially decreased responses to bra-
dykinin at the cellular and behavioral level. These observa-
tions indicate that TRPA1 is an important component of
the transduction machinery that depolarizes nociceptors
in response to endogenous and environmental irritants
or proalgesic agents that elicit inflammatory pain.
RESULTS
TRPA1 Is the Sole Site of Mustard-Oil
and Garlic Action
We generated TRPA1-deficient mice through targeted de-
letion of a genomic region encoding the presumptive
pore-loop domain of the ion channel (Figure 1A; see also
Figure S1 in the Supplemental Data available with this ar-
ticle online). The resulting TRPA1/ mice were normal in
overall appearance and viability, and matings between
heterozygous animals produced wild-type, heterozygous,
and homozygous mutant male and female offspring with
expected Mendelian ratios. RT-PCR using primers that
span the deleted coding region showed that normal
TRPA1 transcripts were absent from trigeminal ganglia
of TRPA1/ animals (Figure 1B). In contrast, TRPM8-
derived PCR products were readily observed in ganglia
from TRPA1+/+ or TRPA1/ mice.
Most, if not all, TRPA1-positive cells are peptidergic
(Bautista et al., 2005; Story et al., 2003), and we therefore
asked whether the prevalence of substance P-expressing
neurons is affected by the absence of TRPA1. Wild-type
and mutant mice exhibited the same prevalence (25%)
of substance P immunoreactive cells within trigeminal or
dorsal root ganglia (Figure 1C). Similarly, capsaicin recep-
tor expression was comparable in wild-type and mutant
mice as determined by immunohistochemical staining
with a TRPV1-specific antiserum (Figure 1C).
To determine whether TRPA1 is solely responsible for
sensitivity to mustard oil (MO) or garlic, we used live-cell
calcium imaging to quantify responses of cultured trigem-
inal neurons to the relevant pungent compounds, allyl iso-
thiocyanate or allicin, respectively. Twenty-five percent of
neurons from newborn (P0) wild-type mice showed rapid
and robust responses to bath-applied MO (50 mM; Figures
2A and 2B) or allicin (200 mM; Figure 2B). As observed
previously in rat neurons (Bautista et al., 2005), all
Figure 1. Generation of TRPA1-Deficient Mice
(A) Targeting strategy for disruption of the TRPA1 gene. Transmembrane and pore-loop protein domains are indicated by black and gray bars, re-
spectively. Exons are numbered and shown as black bars on genomic map. Xb, XbaI; Se, SpeI; Sh, SphI. Blue bar depicts self-excising ACN neo-
mycin expression cassette.
(B) TRPA1 primers designed to amplify a 683 bp fragment within the coding region (beginning at exon 23; see Figure S1) do not generate a product
using first-strand template cDNA from TRPA1/ trigeminal ganglia. As a positive control, an 859 bp portion of TRPM8was amplified from normal and
TRPA1-deficient ganglia.
(C) Immunostaining of trigeminal ganglion shows normal prevalence of TRPV1- and substance P-expressing neurons in TRPA1/ mice.MO-sensitive trigeminal neurons from wild-type mice
were dually responsive to capsaicin (1 mM), accounting
for approximately half of all TRPV1-expressing cells. In
contrast, neurons from TRPA1-deficient mice were com-
pletely insensitive to MO or allicin (Figures 2A and 2B),
demonstrating that TRPA1 is the obligate site of action
for both isothiocyanate and thiosulfinate irritants. Impor-
tantly, the prevalence of capsaicin-responsive cells was
identical in wild-type versus mutant neurons, consistent
with the anatomical results described above. Similar re-
sults were obtained with neurons from dorsal root ganglia
(wild-type: 24% MO-sensitive, 65% capsaicin-sensitive;
TRPA1-deficient: 0% MO-sensitive, 63% capsaicin-
sensitive).
Interestingly, cultures prepared from TRPA1+/ mice
showed only one-third as many MO-sensitive neurons
compared to wild-type controls (10% versus 25%, re-
spectively), and responses were generally smaller or
developed more slowly in neurons from heterozygous an-
imals (Figure 2B and data not shown). This haploinsuffi-
ciency phenotype suggests that the number of functional
TRPA1 channels is limiting such that changes in their ex-
pression or sensitivity can alter neuronal excitation in a
linear and dynamic fashion. It should be mentioned, how-
ever, that RT-PCR analysis using primers located up-Cstream of the deleted region amplify a fragment from tri-
geminal ganglia of TRPA1/ mice (Figure S1), indicating
that a truncated transcript is produced from the disrupted
allele. Thus, it is formally possible that this truncated tran-
script produces a protein fragment (lacking the pore loop
and sixth transmembrane domain) having dominant-neg-
ative activity, which could contribute to the apparent hap-
loinsufficiency phenotype. Unfortunately, direct detection
of such a protein fragment is not possible with existing an-
tibodies, which are directed to the carboxy-terminal tail of
the channel. Finally, while the putative TRPA1 fragment
could have other effects through interaction with un-
specified protein partners, sensory ganglia from TRPA1-
deficient mice show no obvious deficits in capsaicin sen-
sitivity, menthol sensitivity, or calcium handling (Figure 2
and data not shown), and thus we have no direct evidence
to support a dominant-negative effect. In any event, our
results clearly show that functional ablation of the TRPA1
gene leads to selective and complete loss of isothiocya-
nate and thiosulfinate sensitivity without generally affect-
ing cell type specification or sensitivity to other chemical
stimuli.
Topical application of mustard oil to the hindpaw pro-
duces an acute noxious (nocifensive) response, followed
by neurogenic inflammation and robust hypersensitivityell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc. 1271
Figure 2. TRPA1-Deficient Mice Are Insensitive to Mustard Oil
(A) Trigeminal neurons from TRPA1+/+ (left) and TRPA1/ (right) mice were exposed to mustard oil (MO, 100 mM) followed by capsaicin (Cap, 1 mM),
and responses were assessed by calcium imaging. Among Cap-sensitive neurons from wild-type animals, both MO-sensitive (dotted trace) and MO-
insensitive (solid trace) subpopulations were observed. No MO-sensitive cells were detected from TRPA1-deficient mice.
(B) Prevalence of neurons responding to MO (100 mM), allicin (100 mM), or Cap (1 mM) was determined for TRPA1+/+ (black), TRPA1+/ (gray), and
TRPA1/ (red) mice.
(C) Behavioral responses (paw licks or flinches) to MO were measured for TRPA1+/+ and TRPA1/ mice (n = 6 mice/genotype; 5 min duration).
(D) Changes in radiant heat threshold were measured after application of MO to the hindpaw of TRPA1+/+ (black) or TRPA1/ (red) mice. Control
measurements were made using the untreated contralateral hindpaw (white). Baseline responses were not significantly different between genotypes.
Significant differences were observed when comparing TRPA1+/+ ipsilateral paw latencies to the TRPA1+/+ contralateral paw or TRPA1/ ipsilateral
paw (p < 0.001, F = 10; two-way ANOVA). Differences across genotypes at 90 and 120min post-MOwere further analyzed using one-way ANOVAwith
Tukey’s HSD post hoc analyses.
(E) Changes in von Frey hair threshold were measured after MO application to the hindpaw. Baseline responses were not significantly different. Sig-
nificant differences were observed between and TRPA1+/+ and TRPA1/ at 30 and 60 min post-MO (p < 0.001, F = 16; two-way ANOVA) and were
further analyzed using one-way ANOVA with Tukey’s HSD post hoc analyses. Comparisons between wild-type and knockout animals were made
using littermates, and experiments were performed blind to genotype. (*p < 0.05, **p < 0.01, ***p < 0.001; n = 9 per genotype.) All error bars represent
standard error of the mean (SEM).to thermal and mechanical stimuli. We found that acute
behavioral responses (licking and flinching) were abol-
ished in TRPA/ mice, whereas wild-type controls
showed characteristically robust behavior (Figure 2C).1272 Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc.Moreover, TRPA1-deficient animals showed substantially
reduced mustard-oil-evoked swelling of the treated hind-
paw compared to wild-type mice (7% versus 22% in-
crease in thickness). We also measured sensitivity to
thermal and mechanical stimuli before and after mustard-
oil treatment. For wild-type mice, paw-withdrawal laten-
cies from a radiant heat source were characteristically re-
duced after mustard-oil treatment. These animals also
showed a dramatic decrease in the mechanical threshold
for eliciting paw withdrawal (Figures 2D and 2E). In con-
trast, TRPA1-deficient mice showed no hypersensitivity
to either stimulus following mustard-oil treatment. The
slight decrease in thermal sensitivity observed in mutant
animals reflects behavioral desensitization as evidenced
by analysis of the contralateral (control untreated) hind-
paw of wild-type mice, where the same degree of desen-
sitization was observed. These experiments demonstrate
that TRPA1 is essential for mediating sensitivity to mus-
tard oil at both the cellular and behavioral level. Impor-
tantly, wild-type and mutant mice did not differ in baseline
thermal or mechanical thresholds, suggesting that TRPA1
is not required for normal acute sensitivity to heat or pres-
sure.
TRPA1 Mediates Responses to Acrolein and Related
Volatile Irritants
A variety of volatile compounds activate sensory nerve
endings in airways, inducing neurogenic inflammation
and exacerbating chronic cough or asthma (Handzel,
2000; Leikauf, 2002). One such irritant is acrolein (2-pro-
penal), a highly toxic and reactive a,b-unsaturated alde-
hyde present in tear gas, vehicle exhaust, and smoke
from burning vegetation, including tobacco products
(Hales et al., 1988, 1992). Acrolein can induce apnea,
shortness of breath, cough, airway obstruction, and mu-
cous secretion (Ghilarducci and Tjeerdema, 1995). Acro-
lein is also a toxic metabolite of cyclophosphamide and
ifosfamide, chemotherapeutic agents widely used in the
treatment of cancer, severe arthritis, multiple sclerosis,
and lupus (Fleming, 1997; Nicol, 2002). Responses to
acrolein are mediated by capsaicin-sensitive, peptidergic
primary afferent fibers (Ahluwalia et al., 1994; Maggi et al.,
1992; Morris et al., 1999; Springall et al., 1990; Turner
et al., 1993). Additionally, the structurally related irritant
2-pentenal activates capsaicin-sensitive trigeminal neu-
rons in culture (Inoue and Bryant, 2005). However, heterol-
ogously expressed TRPV1 does not respond to acrolein
(Dinis et al., 2004), and TRPV1-deficient mice react nor-
mally to this irritant (Symanowicz et al., 2004), ruling out
a role for the capsaicin receptor as a direct target of acro-
lein action.
TRPA1 is expressed by capsaicin-sensitive neurons
and is therefore an attractive candidate for mediating the
inflammatory actions of acrolein and structurally related ir-
ritants (Figure 3). Because a,b-unsaturated double bonds
are crucial for MO and allicin activity, we hypothesized
that TRPA1may also be sensitive to a,b-unsaturated alde-
hydes such as acrolein. Indeed, we found that acrolein or
2-pentenal (10 mM) produced robust calcium increases in
TRPA1-transfected cells but not in those expressing
TRPV1, TRPV2, or TRPM8 (Figure 4A and data not
shown). Moreover, congeners that have little or no activityCat sensory neurons, such as propionaldehyde, acrylic
acid, and 1-propanol, were inactive at the cloned receptor
(data not shown). We observed an identical pharmacolog-
ical profile with TRPA1-expressing oocytes, where acro-
lein elicited large sustained membrane currents that
were attenuated by ruthenium red, which blocks a number
of TRP channels, including TRPA1. Dose-response analy-
sis revealed a half maximal effective concentration (EC50)
of 5 ± 1 mM (Figure 4B). In trigeminal cultures from wild-
type mice, acrolein and pentenal evoked large increases
in calcium specifically within the subset of capsaicin-
and MO-sensitive neurons. Acrolein-evoked responses
were completely absent in cultures from TRPA1-deficient
mice (Figure 4C), demonstrating that TRPA1 is, indeed, an
essential site for acrolein action.
Sensitivity to Cold Is Preserved in the Absence
of TRPA1
To address the controversial role of TRPA1 in the detec-
tion of cold, we compared the sensitivity of wild-type
and TRPA1-deficient trigeminal neurons to cold thermal
stimuli. Sixteen percent of sensory neurons from wild-
type animals showed robust increases in calcium when
the bath temperature was reduced from 23ºC to 6ºC.
As previously observed with rat sensory neurons
(McKemy et al., 2002; Reid and Flonta, 2002), the majority
of these cold-sensitive cells (78%) responded to a saturat-
ing dose of menthol (250 mM), suggesting that TRPM8 ac-
counts for their cold sensitivity (Figure 5A). The remaining
cold-sensitive cells (22%) were insensitive to menthol or
MO, consistent with the involvement of a TRPM8/
TRPA1-independent mechanism for cold sensitivity in
this subpopulation of trigeminal neurons. Furthermore,
the prevalence andmagnitude of cold- ormenthol-evoked
responses were identical in trigeminal neurons from
TRPA1/ and TRPA1+/+ ganglia (Figure 5A). Similar re-
sults were obtained with cold-sensitive neurons from nor-
mal and mutant dorsal root ganglia (wild-type: 64% men-
thol-sensitive, 36%menthol-insensitive; TRPA1-deficient:
60% menthol-sensitive, 40% menthol-insensitive).
Figure 3. TRPA1 Is Activated by Structurally Related Isothio-
cyanate, Thiosulfinate (Allicin), and Aldehyde (Acrolein and
2-Pentenal) Irritantsell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc. 1273
Figure 4. TRPA1 Is Required for Acrolein Sensitivity
(A) Acrolein (20 mM) evokes calcium influx into hTRPA1-expressing HEK293 cells (top). Cells transfected with hTRPV1 (bottom) are insensitive to acro-
lein but respond to capsaicin (1 mM). Pseudocolor images of Fura-2-loaded cells; scale bar shows intracellular calcium concentration (mM, left).
Graphs display calcium responses as a function of time (right).
(B) Representative current trace (left) and dose-response curve (right) for activation of hTRPA1 by acrolein in voltage-clamped (Vh =60mV) Xenopus
oocytes. Currents were normalized to maximal response obtained with saturating (>100 mM) acrolein; EC50 = 5 ± 1 mM (n = 5 oocytes/data point).
(C) Responses of trigeminal neurons from TRPA1+/+ (left) and TRPA1/ (right) mice to acrolein (100 mM),MO (100 mM), andCap (1 mM)weremeasured
by calcium imaging. Left trace displays average of 100 MO-sensitive neurons; right trace shows average of 100 Cap-sensitive neurons. All error bars
represent standard error of the mean (SEM).We also assessed behavioral cold sensitivity by mea-
suring acute nocifensive responses to acetone-evoked
evaporative cooling or contact with a cold surface. There
were no significant differences in the number of
acetone-evoked paw flinches by wild-type or TRPA1-
deficient mice (Figure 5B). Moreover, latencies for paw1274 Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc.withdrawal or shivering in the cold-plate assay did not dif-
fer with genotype (Figure 5C). Finally, when allowed to
choose between adjacent surfaces adjusted to room tem-
perature versus 15ºC or 10ºC, all animals spent >98% of
the allotted time (5 min) on the room-temperature side, ir-
respective of genotype (data not shown). These findings
Figure 5. TRPA1 Is Not Required for Normal Cold Sensitivity
(A) Trigeminal neurons from TRPA1+/+ (left, black) or TRPA1/ (middle, red) mice were challenged with cold (6ºC) perfusate followed bymenthol (500
mM), and responses weremeasured by calcium imaging. Among cold-sensitive neurons, bothmenthol-sensitive (solid) and -insensitive (dashed) pop-
ulations were observed independent of genotype.
(B) Licking and flinching in response to evaporative cooling was measured following application of acetone (20 ml) to the hindpaw (n = 13 mice/ge-
notype). No significant differences were observed (one-way ANOVA with Tukey’s HSD post hoc analyses).
(C) Paw-withdrawal latency (left) or time to first shiver (right) was measured following placement of mice on an aluminum surface cooled to the indi-
cated temperature. Responses were not significantly different (lift latency: p < 0.93, F = 0.009; shiver latency: p < 0.25, F = 2; two-way ANOVA). Com-
parisons were made using littermates while blind to genotype (n = 13 mice/genotype). All error bars represent standard error of the mean (SEM).are consistent with a lack of involvement of TRPA1 in the
acute detection of cold.
TRPA1-Deficient Mice Have Normal
Auditory Responses
Sensory hair cells in the inner ear use mechanosensitive
channels to transduce auditory and vestibular stimuli
into electrical signals. TRPA1 hasbeen proposed as a can-
didate mechanosensitive transduction channel in the ver-
tebrate inner ear (Corey et al., 2004). If TRPA1 is an essen-
tial component of this transduction machinery, then mice
lacking the channel should display aberrant vestibular
and/or auditory phenotypes. However, we did not observe
overt vestibular phenotypes in TRPA1-deficient mice,
such as circling, altered gait or balance, or poor righting
behavior. Additionally, motor responses to auditory stimuli
(Preyer’s test) were normal in these mice. To evaluate the
status of inner hair-cell function, we analyzed auditory
brainstem responses to a variety of sound-pressure
levels. TRPA1-deficient mice were indistinguishable from
wild-type littermates in that they exhibited similar charac-
teristic responses to both broadband clicks and pure
tones of 8, 16, and 32 kHz stimuli (Figure 6A). Moreover,
TRPA1+/+ and TRPA1/ mice yielded similar distortion
product (Figure 6B), indicative of normal outer hair-cell
function.CeTRPA1 Is Required for Bradykinin-Evoked Excitation
of Sensory Neurons
Based on heterologous-expression studies, we and
others proposed that TRPA1 functions as a receptor-
operated channel, depolarizing nociceptors in response
to proalgesic or proinflammatory agents—such as brady-
kinin, ATP, monoamines, and neurotrophins—that acti-
vate PLC signaling pathways (Bandell et al., 2004; Jordt
et al., 2004). To test this possibility, we used calcium imag-
ing to examine responses of trigeminal neurons to brady-
kinin (10 nM) (Figure 7A). In cultures from wild-type gan-
glia, 19% of neurons showed a moderate rise in calcium
due to release from intracellular stores. Another 30% of
neurons exhibited responses of greater magnitude, virtu-
ally all of which (97%) were MO sensitive. A significant
component of this larger response was due to calcium in-
flux, as it was attenuated by chelation of extracellular cal-
cium (EGTA) or addition of ruthenium red (Figures 7A and
7B). Importantly, the magnitude of bradykinin-evoked cal-
cium responses (peak or integral) correlated with the size
of the MO-evoked response but not with capsaicin
(Figure 7C) or high KCl (75 mM; data not shown), consis-
tent with the notion that bradykinin elicits robust calcium
influx by activating TRPA1 in a subset of sensory neurons.
This was confirmed by the fact that trigeminal neurons
from TRPA1/ mice showed a significant attenuation of
responses to bradykinin (Figures 7A–7C).ll 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc. 1275
Bradykinin elicits thermal hyperalgesia by sensitizing
TRPV1 to heat (Cesare and McNaughton, 1996; Chuang
et al., 2001). Although TRPV1 does not behave as a recep-
tor-operated channel per se, bradykinin-evoked PLC acti-
vation decreases its normal activation threshold (43ºC)
such that small but appreciable currents can be observed
even at room temperature (Chuang et al., 2001). Because
TRPA1 is always coexpressed with TRPV1, this raises the
possibility that TRPV1 acts in concert with TRPA1 to acti-
vate nociceptors in response to bradykinin. Indeed, bra-
dykinin-evoked responses were significantly attenuated
in TRPV1/ trigeminal neurons, resembling the deficit ob-
served with TRPA1/ cells (Figures 7A–7C). Moreover,
while themagnitude ofMO-evoked responseswas normal
in TRPV1-deficient neurons, the correlation between MO
and bradykinin sensitivity was lost (Figure 7C), providing
evidence for a functional coupling between TRPA1 and
TRPV1 in the bradykinin response pathway.
Given the requirement for TRPA1 in the cellular actions
of bradykinin, we asked whether TRPA1-deficient mice
also exhibit behavioral deficits in bradykinin-evoked hy-
peralgesia. We injected bradykinin into the hindpaw of
Figure 6. TRPA1-Deficient Mice Have Normal Hearing
(A) ABR thresholds were measured from the right ears of TRPA1+/+
(black, n = 5) and TRPA1/ (red, n = 6) mice in response to broadband
clicks and 3 ms pure tones of 8, 16, and 32 kHz (mean response ± SD).
No significant differences were observed between genotypes.
(B) Mean DP-grams for TRPA1+/+ (n = 5) and TRPA1/ (n = 6) mice (5–
6 weeks old) were tested by measuring levels of the 2f1-f2 DPOAE over
a geometric-mean frequency range from 5.6 to 48.5 kHz, using an f2/f1
of 1.25 and primary tone stimuli at L1 = L2 = 75 SPL. TRPA1
+/+ and
TRPA1/ mice produced similar distortion product. Noise floors for
both genotypes are displayed (solid lines). All error bars represent
standard error of the mean (SEM).1276 Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc.mice and measured paw withdrawal latencies from a radi-
ant heat source. Wild-type mice showed a characteristic
decrease in latency within minutes of injection, whereas
TRPA1/ mice showed no evidence of hypersensitivity
(Figure 7D). The slight decrease in thermal sensitivity
seen in mutant animals reflects behavioral desensitization
as evidenced by analysis of the contralateral (control
untreated) hindpaw of wild-type mice, where the same
decrease in sensitivity was observed. Injection with com-
plete Freund’s adjuvant (CFA), which produces wholesale
inflammation via both neurogenic and nonneurogenic
mechanisms, induced robust sensitization in wild-type or
mutant animals (Figure 7E). This important control shows
that TRPA1-deficient mice are not generally incapable of
mounting an inflammatory response and, unlike TRPV1-
deficient mice, are not generally defective in their ability
to develop thermal hyperalgesia irrespective of the inflam-
matory mechanism. Our findings suggest that TRPA1 is
a downstream target for specific components of the in-
flammatory milieu, such as bradykinin, that elicit nocicep-
tor excitation and pain hypersensitivity.
DISCUSSION
TRPA1 has been proposed to contribute to a variety of
sensory processes, including thermal (cold) nociception,
mechanosensation, and inflammatory hyperalgesia. While
our results do not support a requirement for this channel in
the initial detection of cold or sound, they clearly demon-
strate a role for TRPA1 in mechanisms of neurogenic in-
flammation and pain hypersensitivity. This is dramatically
illustrated for a variety of exogenous irritants—including
isothiocyanates, thiosulfinates, and a,b-unsaturated alde-
hydes—whose ability to excite nociceptors is entirely de-
pendent on TRPA1 expression. We also show that TRPA1
is an important downstream target of inflammatory
agents, such as bradykinin, that produce nociceptor exci-
tation and/or hypersensitivity via their actions on PLC sig-
naling pathways.
TRPA1 and Environmental Irritants
Different plant genera (e.g., Capsicum versus Brassica
and Allium) have evolved chemically distinct defensive
strategies that target different molecular sites (TRPV1 ver-
sus TRPA1) on primary afferent neurons of the pain path-
way. Despite such segregation at the molecular level,
these agents elicit similar physiological responses (irrita-
tion and inflammation) by exciting an overlapping subpop-
ulation of peptidergic nociceptors. Mustard-oil treatment
has long been used as an important experimental para-
digm for generating and studying mechanisms of inflam-
matory pain. Our findings now prove that TRPA1 is the
obligate site through which MO and chemically related
irritants mediate their actions on the primary afferent ner-
vous system.
Based on in vitro studies, it has been suggested that the
pungency of garlic is mediated through activation of both
TRPA1 and TRPV1 (Macpherson et al., 2005). However,
Figure 7. Both TRPA1 and TRPV1 Are Required for Bradykinin-Evoked Thermal Hyperalgesia
(A) Application of bradykinin (BK, 10 nM) to cultured trigeminal neurons from wild-type mice elicits robust, ruthenium red (RR) sensitive calcium influx
in MO-responsive cells (left). TRPA1-deficient neurons displayed small BK-evoked responses resembling those observed with wild-type cells in the
presence of RR (middle). Similar results were obtained with neurons from TRPV1-deficient animals (right). RR caused no reduction of calcium re-
sponses in TRPA1- or TRPV1-deficient neurons (data not shown).
(B) Bar graph compares average peak intracellular calcium responses for all genotypes or for wild-type neurons in the presence of RR or absence of
extracellular calcium (n = 300–1000 cells/category). Similar results were obtained when comparing integrals of responses (data not shown).
(C) Sensitivity to BK and MO are correlated in sensory neurons. Scatter plots display relationship between BK- and MO- or Cap-evoked calcium re-
sponses in neurons from wild-type, TRPA1/, or TRPV1/ mice. Each point denotes peak calcium response from a single cell.
(D) Paw-withdrawal latencies from a radiant heat source were measured at various times after BK injection. Baseline responses were not significantly
different. Significant differences in latencies were observed between TRPA1+/+ ipsilateral paw (black) compared to the control TRPA1+/+ contralateral
paw (dashed) or the TRPA1/ ipsilateral paw (red) (p < 0.000015, F = 25; two-way ANOVA). Differences at 10, 20, and 30 min were further analyzed
using one-way ANOVA with Tukey’s HSD post hoc analyses (p < 0.009, p < 0.0007, and p < 0.05, respectively). No significant differences were ob-
served between TRPA1+/+ contralateral and TRPA1/ ipsilateral latencies.
(E) Paw-withdrawal latencies from a radiant heat source were measured before and after CFA injection. No significant difference was observed be-
tween wild-type (black) and mutant (red) animals (p < 0.4, F = 0.9; two-way ANOVA). Differences before and after CFA treatment were significant in
both TRPA1+/+ and TRPA1/ mice (one-way ANOVA with Tukey’s post hoc; p < 0.000009 and p < 0.000005, respectively). All error bars represent
standard error of the mean (SEM).Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc. 1277we have shown that cultured neurons from TRPV1-defi-
cient and wild-type mice do not differ in their sensitivity
to allicin or diallyl disulfide, suggesting that TRPV1 does
not contribute significantly to the pungency of theseagents in vivo (Bautista et al., 2005). The complete loss
of allicin-evoked responses among trigeminal neurons
from TRPA1/ mice supports this conclusion and dem-
onstrates that TRPA1 is the sole site through which the
pungent ingredients of mustard and garlic mediate their
excitatory actions.
Original estimates of TRPA1-expressing neurons within
mouse dorsal root ganglia were significantly lower than
the prevalence of MO-sensitive neurons observed in tri-
geminal cultures from rat. Moreover, neuronal responses
to the TRPA1 agonist cinnamaldehyde were less prevalent
than those evoked by isothiocyanates (Bandell et al.,
2004). Based on these observations, it has been sug-
gested that cinnamaldehyde is a more selective TRPA1
agonist than MO and that the latter may act at multiple re-
ceptor sites. Our results with TRPA1-deficient mice now
show that cinnamaldehyde underestimates the preva-
lence of TRPA1-positive neurons and that sensitivity to
MO is specific to cells expressing TRPA1. Indeed, this is
consistent with more recent studies examining the ex-
pression of TRPA1 in trigeminal or dorsal root ganglia us-
ing histological methods (Bautista et al., 2005; Kobayashi
et al., 2005; Nagata et al., 2005).
Another important finding of our study is that TRPA1 is
essential for the action of acrolein. Acrolein initiates neuro-
peptide release from capsaicin-sensitive nerve endings in
the lung or bladder wall, and thus the involvement of pri-
mary afferent fibers in the initial steps of acrolein toxicity
was well established (Ahluwalia et al., 1994; Morris et al.,
1999; Springall et al., 1990; Turner et al., 1993). However,
the molecular target through which acrolein and other
a,b-unsaturated aldehydesmediate their effects remained
unknown. These reactive and volatile irritants pose numer-
ous health risks associated with their ability to promote
neurogenic inflammation through activation of sensory
nerve endings in the airways (Handzel, 2000; Leikauf,
2002; Undem and Carr, 2001). Indeed, acrolein is a major
causative agent of smoke poisoning, producing lung
edema andother forms of respiratory irritation (Ghilarducci
and Tjeerdema, 1995; Leikauf et al., 1989). Identification of
TRPA1 as a nociceptor-specific site of acrolein toxicity
provides a pharmacological target for treating pulmonary
edema and respiratory irritation caused by environmental
irritants of this chemical class—aproblem that is especially
relevant to individuals with chronic cough or asthma.
Acrolein toxicity is also an important factor in the side-
effect profile of chemotherapeutic regimens that use cy-
clophosphamide or ifosfamide to suppress tumor growth
or autoimmunity. Metabolism of these drugs leads to the
production and accumulation of acrolein in urine (Cox,
1979; Takamoto et al., 2004), resulting in complications
such as hemorrhagic cystitis, in which permeabilization
of the bladder vasculature causes severe bleeding, pain,
and termination of therapy (Nicol, 2002). As in the lung,
this pathophysiological response is mediated by excita-
tion of sensory nerve endings in the bladder wall, followed
by neuropeptide release, vasodilation, vascular permeabi-
lization, and other neuroinflammatory effects (Maggi et al.,
1992). TRPA1 antagonists may therefore increase the effi-
cacy of cyclophosphamide-based chemotherapy by
blocking the neuroinflammatory actions of acrolein and re-
lated metabolites.1278 Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc.TRPA1 and the Detection of Cold
TRPA1 was initially proposed to function as a detector of
noxious cold, a hypothesis that was based on two main
observations: (1) Cells heterologously expressing TRPA1
could be activated by temperatures below 17ºC, and
(2) only 4% of mouse dorsal root ganglion neurons were
found to express TRPA1 transcripts, consistent with the
idea that this channel mediates cold sensitivity among
a small subpopulation of menthol-insensitive (TRPM8-
negative) primary afferent neurons (Bandell et al., 2004;
Story et al., 2003). However, cold-evoked responses
have not been uniformly observed in cells expressing
cloned rat or human TRPA1, evenwith extended exposure
to temperatures as low as 5ºC (Jordt et al., 2004; Nagata
et al., 2005). Moreover, the prevalence of MO-responsive
neurons exceeds the total number of cold-sensitive cells
that we observed in rat or mouse trigeminal cultures,
including the menthol-sensitive (TRPM8-positive) and
insensitive (TRPM8-negative) populations. This discrep-
ancy could have been explained by the existence of mul-
tiple MO receptor subtypes, but our results now show that
TRPA1 is the only site at which isothiocyanate compounds
mediate their effects.
Perhaps most importantly, our findings demonstrate
that TRPA1 is not required for acute cold sensitivity at
the cellular or behavioral level. Analysis of cultured trigem-
inal neurons shows no significant difference between nor-
mal and TRPA1-deficient mice in the prevalence of cold-
sensitive neurons or the magnitude of their response to
temperatures as low as 6ºC. Thus, TRPA1 is unlikely to ac-
count for cold sensitivity exhibited by a subpopulation of
menthol-insensitive neurons that we, and others, have ob-
served in cultures from mouse or rat sensory ganglia.
These responses are characterized by a thermal activation
threshold of 15ºC (versus 26ºC for TRPM8), but little
else is known about their biophysical or pharmacological
properties, such as whether they result from the opening
of cationic channels or the closing of background potas-
sium channels (Reid, 2005). Furthermore, our behavioral
studies revealed no significant differences between
TRPA1+/+ and TRPA/mice in their sensitivity to noxious
cold based on their responses to a cooled surface or to
acetone-evoked evaporative cooling, suggesting that
TRPA1 does not function as an initial detector of noxious
cold.
TRPA1 and Inflammatory Hypersensitivity
Bradykinin has long been known to have dual effects on
nociceptors, including acute depolarization and a lon-
ger-lasting hypersensitivity to thermal or mechanical stim-
uli (Dray and Perkins, 1993; McMahon et al., 2006). How-
ever, the cellular signaling mechanisms underlying these
actions have remained elusive, especially in regard to
the identity of channels that mediate acute excitation. A
common feature of many TRP channels is their ability to
be activated or modulated by PLC-coupled signaling
pathways (Montell et al., 2002), making them likely candi-
dates for mediating either of these responses. Indeed,
Figure 8. Model Depicting Functional In-
teractions between Bradykinin Recep-
tors, TRPA1, and TRPV1
BKbinds to Gprotein-coupled receptors on the
surface of primary afferent neurons to activate
phospholipase C (PLC), leading to the hydroly-
sis of membrane phosphatidylinositol bisphos-
phate (PIP2), activation of protein kinase C
(PKC), and release of calcium from intracellular
stores. Consequently, the capsaicin receptor
(TRPV1) is sensitized, leading to channel open-
ing and calcium influx. We hypothesize that the
mustard-oil and garlic receptor (TRPA1) opens
in response to both calcium influx through
TRPV1 and calcium release from intracellular
stores.TRPA1 resembles canonical receptor-operated TRP
channels in that activation of the PLC pathway produces
rapidly developing inward currents, even in the absence
of other known stimuli. TRPA1 has therefore been pro-
posed as a likely candidate to mediate the acute excit-
atory actions of bradykinin or other such proalgesic
agents (Bandell et al., 2004; Jordt et al., 2004). Our find-
ings are consistent with such a role for this channel in vivo.
PLC activation does not robustly activate TRPV1, and
thus we were at first surprised to find that acute excitatory
responses to bradykinin were diminished in TRPV1/
neurons. However, PLC activation does elicit modest
TRPV1 gating and calcium influx, even at room tempera-
ture (Chuang et al., 2001). Moreover, TRPA1 is always
coexpressed with TRPV1, and our previous studies sug-
gest that TRPA1 can be activated by increases in intracel-
lular calcium (Jordt et al., 2004). If so, then bradykinin
could elicit modest calcium influx through TRPV1, which
would then enhance the activation of TRPA1 in these cells.
In this scenario, TRPA1 contributes the bulk of the excit-
atory response. This is further supported by our observa-
tion that the magnitudes of MO- and bradykinin-evoked
responses are no longer correlated in TRPV1-deficient
neurons, as expected if TRPV1 acts upstream of TRPA1.
Moreover, the haploinsufficiency phenotype that we ob-
served (i.e., TRPA1+/ neurons show reduced MO sensi-
tivity compared to wild-type) suggests that TRPA1 levels
are limiting and that changes in its expression or physio-
logical regulatory mechanisms (such as intracellular cal-
cium levels) could have substantial effects on sensory
neuron excitation. Our observations are consistent with
a model in which TRPA1 is activated by bradykinin in
two ways: through PLC-mediated increases in intracellu-
lar calcium (or other metabolites) and via calcium influx
through TRPV1 (Figure 8). It is also possible that loss of
TRPV1 somehow affects TRPA1 expression or vice versa.
However, this seems less likely since we observed no sig-
nificant changes in capsaicin or MO sensitivity in TRPA1-
or TRPV1-deficient neurons, respectively. Additionally,
loss of TRPA1 or TRPV1 could conceivably have an effect
on bradykinin receptor expression, signaling, or calciumChandling. However, our measurements of bradykinin-
evoked calcium transients suggest that this is not the
case for the following reasons: (1) the number of bradyki-
nin-responsive cells is not altered in TRPV1 or TRPA1 mu-
tants, (2) the magnitude of the calcium-release transient
does not change with genotype—only the influx compo-
nent is decreased in mutants, and (3) normal depolariza-
tion-evoked calcium responses are observed in neurons
of all genotypes. Clearly, further studies will be required
to elucidate the exact nature of the functional interaction
between these excitatory TRP channels.
Consistent with the cellular deficits in bradykinin signal-
ing, TRPA1-deficient mice were also refractory to bradyki-
nin-evoked thermal hyperalgesia. However, in contrast to
phenotypes observedwith TRPV1/mice (Caterina et al.,
2000; Davis et al., 2000), TRPA1/ animals exhibited
robust thermal hypersensitivity when challenged with
complete Freund’s adjuvant, which activates multiple in-
flammatory pathways. Because TRPV1 is itself a thermo-
sensor, it stands to reason that animals lacking this chan-
nel exhibit deficits in thermal hyperalgesia irrespective of
the mechanism of tissue injury or inflammation. In con-
trast, TRPA1 appears to act upstream of thermal and me-
chanical detectors, where it is more specifically respon-
sive to a subset of inflammatory mediators that activate
PLC pathways. Other proalgesic agents (e.g., protons
and bioactive lipids) may still excite nociceptors through
parallel, TRPA1-independent pathways to produce pain
hypersensitivity. As such, TRPA1 antagonists may be use-
ful for selective attenuation of specific aspects of inflam-
matory responses contributing to pain.
EXPERIMENTAL PROCEDURES
TRPA1 Gene Disruption
The targeting construct deletedmost of exon 23, encoding the putative
pore and part of the sixth transmembrane domain of mouse TRPA1
(residues 901–951). Genomic DNA flanking this exon (2.5 and 8.8 kb)
was PCR amplified (KOD polymerase, Novagen/Toboyo) from clone
191A9 of the CITB BAC library (Invitrogen), subcloned, and se-
quenced. Fragments were transferred to pACN, a vector with a neomy-
cin cassette that is removed through self-excision in the male germlineell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc. 1279
(Bunting et al., 1999). Linearized targeting construct was transfected
into E14Tg2A.4 mouse ES cells (UCSF Core Facility). G418-resistant
clones were screened for homologous recombination by PCR and ver-
ified by Southern blotting using 50 and 30 flanking probes as well as
a neomycin cassette probe. Targeted ES cell clones were injected
into C57Bl/6 blastocysts and chimeric micemated to C57Bl/6 females.
Heterozygotes were mated to produce paired littermates for all stud-
ies. Germline transmission of the mutated allele and excision of the se-
lection cassette were verified by PCR analysis and Southern blotting.
Gender of newborn pups was determined by PCR amplification of Y
chromosome-specific (Sry) sequences (Koopman et al., 1991).
Histology and PCR
Cryostat sections (10 mm thick) were prepared from paraformalde-
hyde-fixed ganglia as described (Caterina et al., 1999) and incubated
overnight at 4ºC with affinity-purified guinea pig anti-mouse TRPV1
(1:2000; Julius lab) or guinea pig anti-substance P antiserum
(1:20,000; gift of J. Maggio). Primary antisera were visualized with
AlexaFluor 594-coupled goat anti-guinea pig secondary antibody (Invi-
trogen). For RT-PCR, total RNAwas isolated from trigeminal ganglia of
TRPA1/ or TRPA1+/+ mice, and 1 mg was used to synthesize first-
strand cDNA (SuperScript II, Invitrogen) according to manufacturer’s
protocol. PCR was carried out using primers corresponding to nucle-
otides 2695–2727 and 3352–3378 for mTRPA1 and 2072–2093 and
2907–2931 for mTRPM8.
Calcium Imaging and Oocyte Electrophysiology
Dissociation and culturing of mouse sensory neurons, heterologous
expression of TRPA1 in HEK293 cells or oocytes, calcium imaging,
and two-electrode voltage clamp were carried out as described (Bau-
tista et al., 2005; Jordt et al., 2004). Neuronal imaging was performed
using ganglia from littermates while blind to genotype.
Behavior
Mice (20–35 g) were housed with 12 hr light/dark cycle at 21ºC, and ex-
periments were performed under the policies of the International Asso-
ciation for the Study of Pain and the UCSF Animal Care and Use Com-
mittee. 50% mechanical threshold was determined with von Frey hair
filaments using the ‘‘up and down paradigm’’ (Chaplan et al., 1994),
starting with 0.1 g and ending with 2.0 g filament as cutoff value. Nox-
ious heat thresholds were determined using an adaptation of the radi-
ant heat test (Hargreaves et al., 1988) with a cutoff value of 20 s to pre-
vent injury. Nocifensive responses and thermal and mechanical
hyperalgesia following MO application or bradykinin injection (25 g
male mice) weremeasured as described (Caterina et al., 2000; Chuang
et al., 2001). Hindpaw thickness was determined with spring-loaded
caliper before and 1 and 2 hr after agonist application/injection. For ac-
etone-evokedevaporative cooling, animalswere habituated in a plastic
enclosure on amesh floor, and 0.05ml acetone applied fromadistance
of 2 mm from the hindpaw. Flinching and licking was measured as de-
scribed (Martinez-Caro and Laird, 2000) and repeated five times every
5 min. For cold-plate tests, the temperature of an aluminum block was
controlled by fluid circulation (+20ºC to 10ºC). Time to first response
of forelimb shivering or hindpaw lifting was recordedwith a 300 s cutoff
to prevent injury. Complete Freund’s adjuvant (10 mg in saline, Sigma,
CFA) was injected into one hindpaw (20 ml), and thermal latencies and
paw thickness were measured after 24 hr. Data were analyzed using
two- or one-way ANOVA with Tukey’s HSD post hoc analysis. Behav-
ioral tests were performed by one individual blind to genotype.
Auditory Brainstem Responses
Ear twitch responses were determined for wild-type and TRPA1-defi-
cient littermates (n = 5 per genotype) with a handclap (Preyer’s reflex)
to grossly assess the hearing status. Mice (5–6 weeks old) were anes-
thetizedwith avertin, and auditory brainstem response (ABR)measure-
ments were recorded as described (Dou et al., 2004). Briefly, a ground
needle electrode and recording needle were placed subcutaneously in1280 Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc.the scalp, and a calibrated electrostatic speaker coupled to a hollow
ear bar was placed inside the pinna. Broadband clicks and pure tones
(8, 16, and 32 kHz) were presented in the ear in 10 dB increments, from
0 to 100 dB SPL. The ABR sweeps were computer averaged (time
locked with onset of 128–1024 stimuli, at 20/s) out of the continuous
electroencephalographic activity. Hearing threshold was determined
as the lowest intensity of sound required to elicit a characteristic wave-
form.
Distortion Product Otoacoustic Emissions (DPOAE)
Mice were anesthetized with ketamine (95 mg/kg) and xylazine (4 mg/
kg). The f1 and f2 primary tones were generated by a two-channel fre-
quency synthesizer (HP 3326A) presented over two tweeters (Realistic)
and delivered through a soft rubber probe. Ear-canal sound pressure
was measured with a commercial acoustic probe (Etymotic Research
10B+). Ear-canal sound pressure was sampled and synchronously av-
eraged (n = 8) by a digital signal processor for frequencies <20.1 kHz
and a dynamic signal analyzer (HP 3561A) for frequencies
>20.1 kHz. DP-grams were collected over a range of geometric
mean frequencies between 5.6 and 48.5 kHz (f2 = 6.354.2 kHz), in
0.5 octave intervals at stimulus levels of L1 = L2 = 75 dB SPL, with
f2/f1 = 1.25.
Supplemental Data
Supplemental Data include one figure and can be found with this article
online at http://www.cell.com/cgi/content/full/124/6/1269/DC1/.
ACKNOWLEDGMENTS
We thank N. Shah for advice regarding gene targeting, E. Lumpkin and
B. Piskorowski for helpful discussions, G. Hollopeter for assistance
with histology, and M. Capecchi for use of the pACN targeting vector.
This work was supported by grants from NINDS (D.J.), NIDCR (D.J.
and A.I.B.), and NIDCD (E.N.Y.) and a NIH postdoctoral fellowship
and Burroughs Welcome Fund Career Award in Biomedical Science
(D.M.B.).
Received: November 30, 2005
Revised: January 6, 2006
Accepted: February 8, 2006
Published: March 23, 2006
REFERENCES
Ahluwalia, A., Maggi, C.A., Santicioli, P., Lecci, A., and Giuliani, S.
(1994). Characterization of the capsaicin-sensitive component of
cyclophosphamide-induced inflammation in the rat urinary bladder.
Br. J. Pharmacol. 111, 1017–1022.
Bandell, M., Story, G.M., Hwang, S.W., Viswanath, V., Eid, S.R., Pet-
rus, M.J., Earley, T.J., and Patapoutian, A. (2004). Noxious cold ion
channel TRPA1 is activated by pungent compounds and bradykinin.
Neuron 41, 849–857.
Bautista, D.M., Movahed, P., Hinman, A., Axelsson, H.E., Sterner, O.,
Hogestatt, E.D., Julius, D., Jordt, S.E., and Zygmunt, P.M. (2005). Pun-
gent products from garlic activate the sensory ion channel TRPA1.
Proc. Natl. Acad. Sci. USA 102, 12248–12252.
Bunting, M., Bernstein, K.E., Greer, J.M., Capecchi, M.R., and
Thomas, K.R. (1999). Targeting genes for self-excision in the germ
line. Genes Dev. 13, 1524–1528.
Caterina, M.J., Rosen, T.A., Tominaga, M., Brake, A.J., and Julius, D.
(1999). A capsaicin-receptor homologue with a high threshold for nox-
ious heat. Nature 398, 436–441.
Caterina, M.J., Leffler, A., Malmberg, A.B., Martin, W.J., Trafton, J.,
Petersen-Zeitz, K.R., Koltzenburg, M., Basbaum, A.I., and Julius, D.
(2000). Impaired nociception and pain sensation in mice lacking the
capsaicin receptor. Science 288, 306–313.
Cesare, P., andMcNaughton, P. (1996). A novel heat-activated current
in nociceptive neurons and its sensitization by bradykinin. Proc. Natl.
Acad. Sci. USA 93, 15435–15439.
Cesare, P., Moriondo, A., Vellani, V., andMcNaughton, P.A. (1999). Ion
channels gated by heat. Proc. Natl. Acad. Sci. USA 96, 7658–7663.
Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M., and Yaksh, T.L.
(1994). Quantitative assessment of tactile allodynia in the rat paw.
J. Neurosci. Methods 53, 55–63.
Chuang, H.H., Prescott, E.D., Kong, H., Shields, S., Jordt, S.E., Bas-
baum, A.I., Chao, M.V., and Julius, D. (2001). Bradykinin and nerve
growth factor release the capsaicin receptor from PtdIns(4,5)P2-medi-
ated inhibition. Nature 411, 957–962.
Clapham, D.E. (2003). TRP channels as cellular sensors. Nature 426,
517–524.
Corey, D.P., Garcia-Anoveros, J., Holt, J.R., Kwan, K.Y., Lin, S.Y., Voll-
rath,M.A., Amalfitano, A., Cheung, E.L., Derfler, B.H., Duggan, A., et al.
(2004). TRPA1 is a candidate for the mechanosensitive transduction
channel of vertebrate hair cells. Nature 432, 723–730.
Cox, P.J. (1979). Cyclophosphamide cystitis—identification of acrolein
as the causative agent. Biochem. Pharmacol. 28, 2045–2049.
Davis, J.B., Gray, J., Gunthorpe, M.J., Hatcher, J.P., Davey, P.T.,
Overend, P., Harries, M.H., Latcham, J., Clapham, C., Atkinson, K.,
et al. (2000). Vanilloid receptor-1 is essential for inflammatory thermal
hyperalgesia. Nature 405, 183–187.
Dinis, P., Charrua, A., Avelino, A., Yaqoob, M., Bevan, S., Nagy, I., and
Cruz, F. (2004). Anandamide-evoked activation of vanilloid receptor 1
contributes to the development of bladder hyperreflexia and nocicep-
tive transmission to spinal dorsal horn neurons in cystitis. J. Neurosci.
24, 11253–11263.
Dou, H., Vazquez, A.E., Namkung, Y., Chu, H., Cardell, E.L., Nie, L.,
Parson, S., Shin, H.S., and Yamoah, E.N. (2004). Null mutation of al-
pha1D Ca2+ channel gene results in deafness but no vestibular defect
in mice. J. Assoc. Res. Otolaryngol. 5, 215–226.
Dray, A., and Perkins, M. (1993). Bradykinin and inflammatory pain.
Trends Neurosci. 16, 99–104.
Dunn, P.M., and Rang, H.P. (1990). Bradykinin-induced depolarization
of primary afferent nerve terminals in the neonatal rat spinal cord
in vitro. Br. J. Pharmacol. 100, 656–660.
Fleming, R.A. (1997). An overview of cyclophosphamide and ifosfa-
mide pharmacology. Pharmacotherapy 17, 146S–154S.
Ghilarducci, D.P., and Tjeerdema, R.S. (1995). Fate and effects of
acrolein. Rev. Environ. Contam. Toxicol. 144, 95–146.
Hales, C.A., Barkin, P.W., Jung, W., Trautman, E., Lamborghini, D.,
Herrig, N., and Burke, J. (1988). Synthetic smoke with acrolein but
not HCl produces pulmonary edema. J. Appl. Physiol. 64, 1121–1133.
Hales, C.A., Musto, S.W., Janssens, S., Jung, W., Quinn, D.A., and
Witten, M. (1992). Smoke aldehyde component influences pulmonary
edema. J. Appl. Physiol. 72, 555–561.
Handzel, Z.T. (2000). Effects of environmental pollutants on airways,
allergic inflammation, and the immune response. Rev. Environ. Health
15, 325–336.
Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J. (1988). A
new and sensitive method for measuring thermal nociception in cuta-
neous hyperalgesia. Pain 32, 77–88.
Inoue, T., and Bryant, B.P. (2005). Multiple types of sensory neurons
respond to irritating volatile organic compounds (VOCs): calcium fluo-
rimetry of trigeminal ganglion neurons. Pain 117, 193–203.
Jordt, S.E., McKemy, D.D., and Julius, D. (2003). Lessons from pep-
pers and peppermint: the molecular logic of thermosensation. Curr.
Opin. Neurobiol. 13, 487–492.
Jordt, S.E., Bautista, D.M., Chuang, H.H., McKemy, D.D., Zygmunt,
P.M., Hogestatt, E.D., Meng, I.D., and Julius, D. (2004). Mustard oilsCand cannabinoids excite sensory nerve fibres through the TRP channel
ANKTM1. Nature 427, 260–265.
Julius, D., and Basbaum, A.I. (2001). Molecular mechanisms of noci-
ception. Nature 413, 203–210.
Kobayashi, K., Fukuoka, T., Obata, K., Yamanaka, H., Dai, Y., Toku-
naga, A., and Noguchi, K. (2005). Distinct expression of TRPM8,
TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with
adelta/c-fibers and colocalization with trk receptors. J. Comp. Neurol.
493, 596–606.
Kollarik, M., and Undem, B.J. (2004). Activation of bronchopulmonary
vagal afferent nerves with bradykinin, acid and vanilloid receptor ago-
nists in wild-type and TRPV1/ mice. J. Physiol. 555, 115–123.
Koopman, P., Gubbay, J., Vivian, N., Goodfellow, P., and Lovell-
Badge, R. (1991). Male development of chromosomally female mice
transgenic for Sry. Nature 351, 117–121.
Leikauf, G.D. (2002). Hazardous air pollutants and asthma. Environ.
Health Perspect. 110 Suppl. 4, 505–526.
Leikauf, G.D., Leming, L.M., O’Donnell, J.R., and Doupnik, C.A. (1989).
Bronchial responsiveness and inflammation in guinea pigs exposed to
acrolein. J. Appl. Physiol. 66, 171–178.
Macpherson, L.J., Geierstanger, B.H., Viswanath, V., Bandell, M., Eid,
S.R., Hwang, S., and Patapoutian, A. (2005). The pungency of garlic:
activation of TRPA1 and TRPV1 in response to allicin. Curr. Biol. 15,
929–934.
Maggi, C.A., Lecci, A., Santicioli, P., Del Bianco, E., and Giuliani, S.
(1992). Cyclophosphamide cystitis in rats: involvement of capsaicin-
sensitive primary afferents. J. Auton. Nerv. Syst. 38, 201–208.
Martinez-Caro, L., and Laird, J.M. (2000). Allodynia and hyperalgesia
evoked by sciatic mononeuropathy in NKI receptor knockout mice.
Neuroreport 11, 1213–1217.
McKemy, D.D., Neuhausser, W.M., and Julius, D. (2002). Identification
of a cold receptor reveals a general role for TRP channels in thermo-
sensation. Nature 416, 52–58.
McMahon, S.B., Bennett, D.L.H., and Bevan, S. (2006). Inflammatory
mediators andmodulators of pain. In Textbook of Pain, S.B. McMahon
and M. Koltzenburg, eds. (Philadelphia: Elsevier), pp. 49–72.
Montell, C., Birnbaumer, L., and Flockerzi, V. (2002). The TRP chan-
nels, a remarkably functional family. Cell 108, 595–598.
Morris, J.B., Stanek, J., and Gianutsos, G. (1999). Sensory nerve-
mediated immediate nasal responses to inspired acrolein. J. Appl.
Physiol. 87, 1877–1886.
Nagata, K., Duggan, A., Kumar, G., and Garcia-Anoveros, J. (2005).
Nociceptor and hair cell transducer properties of TRPA1, a channel
for pain and hearing. J. Neurosci. 25, 4052–4061.
Nicol, D. (2002). Cyclophosphamide and the urinary tract. Intern. Med.
J. 32, 199–201.
Premkumar, L.S., and Ahern, G.P. (2000). Induction of vanilloid recep-
tor channel activity by protein kinase C. Nature 408, 985–990.
Reid, G. (2005). ThermoTRP channels and cold sensing: what are they
really up to? Pflugers Arch. 451, 250–263.
Reid, G., and Flonta, M.L. (2002). Ion channels activated by cold and
menthol in cultured rat dorsal root ganglion neurones. Neurosci. Lett.
324, 164–168.
Springall, D.R., Edginton, J.A., Price, P.N., Swanston, D.W., Noel, C.,
Bloom, S.R., and Polak, J.M. (1990). Acrolein depletes the neuropep-
tides CGRP and substance P in sensory nerves in rat respiratory tract.
Environ. Health Perspect. 85, 151–157.
Story, G.M., Peier, A.M., Reeve, A.J., Eid, S.R., Mosbacher, J., Hricik,
T.R., Earley, T.J., Hergarden, A.C., Andersson, D.A., Hwang, S.W.,
et al. (2003). ANKTM1, a TRP-like channel expressed in nociceptive
neurons, is activated by cold temperatures. Cell 112, 819–829.ell 124, 1269–1282, March 24, 2006 ª2006 Elsevier Inc. 1281
Symanowicz, P.T., Gianutsos, G., and Morris, J.B. (2004). Lack of role
for the vanilloid receptor in response to several inspired irritant air pol-
lutants in the C57Bl/6J mouse. Neurosci. Lett. 362, 150–153.
Takamoto, S., Sakura, N., Namera, A., and Yashiki, M. (2004). Monitor-
ing of urinary acrolein concentration in patients receiving cyclophos-
phamide and ifosphamide. J. Chromatogr. B Analyt. Technol. Biomed.
Life Sci. 806, 59–63.1282 Cell 124, 1269–1282, March 24, 2006 ª2006 Elsevier IncTurner, C.R., Stow, R.B., Talerico, S.D., Christian, E.P., and Williams,
J.C. (1993). Protective role for neuropeptides in acute pulmonary re-
sponse to acrolein in guinea pigs. J. Appl. Physiol. 75, 2456–2465.
Undem, B.J., and Carr, M.J. (2001). Pharmacology of airway afferent
nerve activity. Respir. Res. 2, 234–244.
Wang, H., and Woolf, C.J. (2005). Pain TRPs. Neuron 46, 9–12..
